Delivery Order HHSN261201600008I-75N91019F00129

This is a firm fixed-price delivery order awarded by the National Cancer Institute to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center in Los Angeles, under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The $48,999.75 award is for providing tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is funded through the American Recovery and Reinvestment Act (ARRA). The work is to be completed...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The contract, valued at $20,636.55, is part of the NCI Cancer Genome Atlas Program and supports the collection of tissue samples and data from various types of cancer for the program. The contract does not have a set-aside designation. Cedars-Sinai Medical Center is an...

This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Cedars-Sinai Medical Center. The $21,934 firm-fixed-price contract was awarded on July 14, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery vehicle. The contract supports the collection of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program, which aims to comprehensively characterize...

This federal contract award is for a Tissue Source Site (TSS) to support the National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The prime contractor, William Beaumont Hospital, doing business as Beaumont Health, is a non-profit hospital that will provide tissue samples for the CPTAC cancer research initiative. The contract has a ceiling value of $3,844.62 and an ultimate completion date of July 14, 2021. It is a firm fixed price delivery order under a...

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poland. The contract is for Tissue Source Site (TSS) services in support of NCI's Clinical Proteomic Tumor Analysis Consortium, specifically for the analysis of 100 cases across Payments 1-3 at a rate of $2,000 per case (with an 85% payment factor). The total ceiling value of the contract is $402,700. This delivery order is part of...

This is a $2,502,392.00 definitive contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services (HHS), to Case Western Reserve University to establish a Tissue Source Site (TSS) Network in support of the Cancer Genome Atlas (TCGA) program. The contract has a period of performance through September 30, 2014 and does not have a set-aside designation. The purpose of the contract is to provide clinically annotated biospecimens to the TCGA's...

This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Biomatrix LLC, a woman-owned, Asian-Pacific American-owned limited liability company, for providing a Tissue Source Site (TSS) in support of the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract is a Delivery Order with a Firm Fixed Price valued at $231,228.50. It does not have a set-aside designation and...

This is a firm-fixed price delivery order contract awarded by the National Cancer Institute, part of the National Institutes of Health, to Thomas Jefferson University, doing business as Sidney Kimmel Medical College. The contract, which is not designated as a set-aside, is for the recovery and provision of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, an initiative under the American Recovery and Reinvestment Act. The contract has a ceiling...

This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Regents of the University of California, San Francisco (UCSF) for the Cancer Genome Atlas (TCGA) program. The contract, valued at $24,087.50, is for the acquisition of tissue samples and data from various types of cancer to support the TCGA program, which is part of the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation and is a firm fixed-price type. UCSF, as...

This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Biomatrix LLC, a woman-owned and Asian-Pacific American-owned limited liability company, for $348,699.80. The award is for Biomatrix to serve as a Tissue Source Site (TSS) for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract has a period of performance through April 29, 2019 and does not have a set-aside designation. The CPTAC program is focused on the...